Trinity revenues up a fifth in Q2
Dublin-based Trinity Biotech, which trades on the ISEQ and on New York’s NASDAQ, has announced results for the quarter ended June 30, 2004.
Revenues in the quarter increased 22.6% to $20.1m (€16.7m) compared to $16.4m (€13.6m) in quarter one.